BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9390123)

  • 21. Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? A HARNET Study.
    Slawson DC; Bennett JH; Herman JM
    J Fam Pract; 1993 Mar; 36(3):289-93. PubMed ID: 8454975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appropriate follow-up interval for biopsy confirmation of squamous intraepithelial lesions diagnosed by cervical smear cytology.
    Renshaw AA; Granter SR
    Am J Clin Pathol; 1997 Sep; 108(3):275-9. PubMed ID: 9291454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cervical cytological abnormalities in Turkish population.
    Atilgan R; Celik A; Boztosun A; Ilter E; Yalta T; Ozercan R
    Indian J Pathol Microbiol; 2012; 55(1):52-5. PubMed ID: 22499301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening errors in cervical cytologic screening.
    van der Graaf Y; Vooijs GP; Gaillard HL; Go DM
    Acta Cytol; 1987; 31(4):434-8. PubMed ID: 3604538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses.
    Sherman ME; Schiffman MH; Erozan YS; Wacholder S; Kurman RJ
    Arch Pathol Lab Med; 1992 Nov; 116(11):1155-8. PubMed ID: 1444745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the abnormal Pap smear.
    Homesley HD
    Am Fam Physician; 1977 Sep; 16(3):190-4. PubMed ID: 900003
    [No Abstract]   [Full Text] [Related]  

  • 27. Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management.
    Rader AE; Rose PG; Rodriguez M; Mansbacher S; Pitlik D; Abdul-Karim FW
    Acta Cytol; 1999; 43(3):357-62. PubMed ID: 10349362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma.
    Sherman ME; Mango LJ; Kelly D; Paull G; Ludin V; Copeland C; Solomon D; Schiffman MH
    Mod Pathol; 1994 Jun; 7(5):578-81. PubMed ID: 7937724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer.
    Kristensen GB; Skyggebjerg KD; Hølund B; Holm K; Hansen MK
    Acta Cytol; 1991; 35(1):47-50. PubMed ID: 1994634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. False negative rate of cervical cytologic smear screening as determined by rapid rescreening.
    Renshaw AA; Bellerose B; DiNisco SA; Minter LJ; Lee KR
    Acta Cytol; 1999; 43(3):344-50. PubMed ID: 10349360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenocarcinoma in situ of the cervix.
    Schoolland M; Segal A; Allpress S; Miranda A; Frost FA; Sterrett GF
    Cancer; 2002 Dec; 96(6):330-7. PubMed ID: 12478680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cellularity on the sensitivity of detecting squamous lesions in liquid-based cervical cytology.
    Studeman KD; Ioffe OB; Puszkiewicz J; Sauvegeot J; Henry MR
    Acta Cytol; 2003; 47(4):605-10. PubMed ID: 12920754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transitional cell metaplasia of the cervix: a newly described entity in cervicovaginal smears.
    Weir MM; Bell DA
    Diagn Cytopathol; 1998 Mar; 18(3):222-6. PubMed ID: 9523143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualification of atypical squamous cells of undetermined significance in an independent laboratory: is it useful or significant?
    Lachman MF; Cavallo-Calvanese C
    Am J Obstet Gynecol; 1998 Aug; 179(2):421-9. PubMed ID: 9731848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective review of cervical cytology in women developing invasive squamous cell carcinoma.
    Walker EM; Hare MJ; Cooper P
    Br J Obstet Gynaecol; 1983 Nov; 90(11):1087-91. PubMed ID: 6639901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of squamous abnormalities in women with a recent smear without endocervical cells is lower as compared to women with smears with endocervical cells.
    Siebers AG; de Leeuw H; Verbeek AL; Hanselaar AG
    Cytopathology; 2003 Apr; 14(2):58-65. PubMed ID: 12713476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of diagnoses of endocervical glandular abnormalities in cervical smears.
    Segal A; Frost FA; Miranda A; Fletcher C; Sterrett GF
    Pathology; 2003 Jun; 35(3):198-203. PubMed ID: 14506961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of tumor diathesis in smears from women with squamous cell carcinoma of the cervix.
    Rushing L; Cibas ES
    Acta Cytol; 1997; 41(3):781-5. PubMed ID: 9167702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reclassification of atypical immature metaplasia of the uterine cervix by combination of nuclear features on hematoxylin and eosin-stained sections without auxiliary immunohistochemistry.
    Imai Y; Fukagawa Y; Sugihara S; Teranishi T
    Hum Pathol; 2022 Nov; 129():113-122. PubMed ID: 36245140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thin-layer (liquid-based) cytologic findings of papillary squamotransitional cell carcinoma of the cervix. Review of cases over a 4-year period with emphasis on potential diagnostic pitfalls.
    Ng WK
    Acta Cytol; 2003; 47(2):141-8. PubMed ID: 12685179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.